This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on ISI (19)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Colon Cancer  • Radiation Therapy  • Gastrointestinal Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

Karlheinz Ammann, MD; Werner Kirchmayr, MD; Alexander Klaus, MD; Gilbert Mühlmann, MD; Reinhold Kafka, MD; Michael Oberwalder, MD; Alexander De Vries, MD, PhD; Dietmar Öfner, MD, PhD; Helmut Weiss, MD, PhD

Arch Surg. 2003;138:257-261.

Hypothesis  Preoperative chemoradiation for patients with stage II and III midrectal and low rectal cancer may improve survival and decrease local recurrence rate. We evaluated the long-term impact of neoadjuvant chemoradiation on anal sphincter function.

Design  Prospective analysis.

Setting  Tertiary referral center.

Patients  From March 1, 1996, to January 31, 2002, 50 patients with midrectal and low rectal cancer who underwent total mesorectal excision were prospectively enrolled.

Interventions  Patients received either surgical therapy alone (group 1, n = 22) or preoperative, combined chemoradiation (group 2, n = 28). Group 2 was divided into patients with midrectal (group 2A, n = 14) and low rectal (group 2B, n = 14) cancer. Anorectal manometry was performed preoperatively and a median of 384 days postoperatively.

Main Outcome Measures  Anal resting pressure, squeeze pressure, anal sphincter vector volumes, length of the high-pressure zone, sensory threshold of the pouch, and rectal capacity.

Results  Preoperative manometric values were comparable between the groups. No statistically significant manometric differences occurred in group 1 postoperatively. Mean resting pressure (preoperative and postoperative, respectively: 89 ± 35 mm Hg, 53 ± 17 mm Hg), resting vector volume (605 ± 324 cm³, 142 ± 88 cm³), and maximal tolerable volume (144 ± 29 mL, 82 ± 44 mL) decreased significantly in chemoradiated patients postoperatively (P<.05). Manometric values of group 2B patients remained stable postoperatively, while mean resting pressure (73 ± 22 mm Hg vs 52 ± 14 mm Hg) and resting vector volume (631 ± 288 cm³ vs 145 ± 78 cm³) decreased significantly in group 2A patients (P<.001).

Conclusions  Total mesorectal excision does not influence anal sphincter function during long-term follow-up. Neoadjuvant chemoradiation results in disordered anal sphincter function in patients with midrectal cancer. Low and rectoanal anastomosis seems to obtain better anal sphincter function than higher anastomosis in chemoradiated patients.

From the Departments of General Surgery (Drs Ammann, Kirchmayr, Klaus, Mühlmann, Kafka, Oberwalder, Öfner, and Weiss) and Radio-Oncology (Dr De Vries), University Hospital Innsbruck, Innsbruck, Austria.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?